代谢综合征与脂肪因子的联系
摘要
代谢综合征(MS)是由于长期胰岛素抵抗(TR)和高胰岛素血症所引发的一系列密切相关的异常临床表现。脂肪组织能够以旁分泌、自分泌和远距分泌方式产生生物活性因子或因子样分子,称为脂肪因子。目前的研究表明:这些脂肪因子通过影响胰岛素敏感性、血压水平、内皮功能、纤溶活动及炎性反应,
参考文献13
-
1Minokoshi Y,Kim YB,Peroni OD,et al.Leptin stimulatesfatty-acid oxidation by activating AMP-activated protein kinasea[J].Nature,2002,415:339.
-
2Haj FG,Zabolotny JM,Kim YB,et al.Liver specific protein-tyrosine phosphatase1B(PTP1B)re-expression alters glucosehomeostasis of PTP1B-/-mice[J].J Biol Chem,2005,280:15038.
-
3La cava A,Alv Iggic.Matarese G1Unraveling the multiple roles of leptin in inflammation and autoimmunity[J].J MolMed,2004,82(1):4.
-
4Pravenec M,Kazdova L,Landa V,et al.Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat[J].J Biol Chem,2004,278:45209.
-
5Yoda2Murakami M,Taniguchi M,Takahashi K,et al.Change in expression of GBP28/adi-ponectin in carbon tetrachloride-administrated mouse liver[J].Biochem Biophys Res Commun,2001,285:372-377.
-
6Maeda N,Shimomura I,Kishida K,et al.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30[J].Nat Med,2002,8:731.
-
7Park J,Rho HK,Kim KH,et al.Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity[J].Mol Cell Biol,2005,25:5146.
-
8KimJA,Yeh DC,Ver M,et al.Phosphorylation of Ser24in the pleckstrin homology domain of insulin receptor substrate-1by Mouse Pelle-like kinase/interleukin-1receptor-associated kinase:cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance[J].J BiolChem,2005,280:23173.
-
9Medina EA,Afsari RR,Ravid T,et al.Tumor necrosis factor-(alpha)decreases Akt protein levels in3T32L1adipocytes via the caspase dependent ubiquitination of Akt[J].Endocrinology,2005,146:2726.
-
10Nordstrom EA,Ryden M,Backlund EC,et al.A human-specific role of cell death-inducing DFFA[DNA fragmentation factor-(alpha)]-like effector A(CIDEA)in adipocyte lipolysis and obesity[J].Diabetes,2005,54:1726.
-
1毛节明,郭艳红.脂肪细胞因子与动脉粥样硬化[J].中国循环杂志,2008,23(2):81-82. 被引量:4
-
2李明蔚,顾丽群,邵洁.脂联素与胰岛素抵抗[J].内科理论与实践,2009,4(6):522-525. 被引量:7
-
3谢谦,张帆,胡小平.脂联素-一种负性脂肪因子[J].临床和实验医学杂志,2008,7(8):186-186. 被引量:6
-
4鲍行峰.高血压患者血清胆红素与脂联素的变化及临床意义[J].中国基层医药,2010,17(13):1831-1832. 被引量:1
-
5李海英.右室肥厚与生物活性因子的研究进展[J].中华医学写作杂志,2002,9(24):2158-2161.
-
6于丹,马红.脂联素与慢性肝病的关系研究进展[J].肝脏,2007,12(5):412-413. 被引量:1
-
7余淑芳.诺和灵30R治疗2型糖尿病血糖不满意者改用诺和锐30疗效分析[J].实用糖尿病杂志,2010(4):48-49. 被引量:2
-
8李文强,李艳,周永明,周青,李庚山.扩张型心肌病与肥厚型心肌病患者血浆脑钠肽的比较[J].中华老年心脑血管病杂志,2005,7(3):191-191. 被引量:2
-
9张献玲,吴立群.脂联素及其基因多态性与冠心病的研究进展[J].中华内科杂志,2009,48(7):601-602. 被引量:2
-
10李晓燕,郭文静.脂联素、内皮祖细胞与心血管疾病[J].中国循证心血管医学杂志,2012,4(3):177-179. 被引量:2